NCI Director's Awards 2005 - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp online chat

	NCI Highlights


	U.S. and Four Latin American Countries Partner to Battle Cancer U.S. and Republic of Chile Partner to Battle Cancer The Nation's Investment in Cancer Research FY 2010 Cancer Trends Progress Report: 2007 Update NCI Participation in the NIH Roadmap

• Group Awards
• Individual Awards
• Merit Awards Commissioned Corps
• Leading Diversity Award
• Length of Service Certificates
• Outstanding Mentor Award
• Mentors of Merit

Group Awards



Kevin A. Camphausen, M.D. James B. Mitchell, Ph.D. In recognition of outstanding achievement in radiation research, leading to greatly improved cancer therapies. Lionel Feigenbaum, Ph.D. Lino Tessarollo, Ph.D. For outstanding contributions to the creation of genetically engineered animal models crucial to the study of human diseases. Dao M. Nguyen, M.D. David S. Schrump, M.D. For providing exemplary thoracic surgery support for all NIH protocols, and for developing an innovative translational research program in Thoracic Oncology. Christiaan R. de Vries , B.A. Mary B. Ganges, B.S. Katherine A. Hogan, B.S. Azam V. Nahvi, B.S. Linda L. Parker, B.S. Michelle M. Pelletier, B.A. Thomas E. Shelton, M.S. Armen A. Thomasian, B.S. The technicians of the Surgery Branch's Cell Production Facility have demonstrated outstanding dedication, resourcefulness and perseverance to generate successful, novel immunotherapies for patients with cancer. Susan H. Garfield , M.S. Tatiana S. Karpova, Ph.D. Stephen J. Lockett, B.Sc., M.Sc., Ph.D. James G. McNally, Ph.D. Stephen M. Wincovitch, Sr., M.S. For developing innovative projects and providing technical support, training and expertise to hundreds of investigators in the fluorescence microscopy field for basic and translational research. Wendy D. du Bois, B.S. Maudeline Etienne, B.S. Vaishali Jarral, B.S. Luis Rivera Tina M. Wellington Nicole L. Wrice, B.S. For outstanding service in constructing animal models and conducting tumor induction studies for the Laboratory of Genetics, CCR, NCI Collette M. Bramwell Linda J. Finneyfrock Mary B. Gregg, M.B.A., M.S. Elaine A. Hauschildt Rosanne A. Hurwitz, J.D., M.P.H. Abbie F. Mimiko Cynthia D. Morgan, B.S. Cheryl Lynn Nelson Danielle N. Stewart Shari M. Wahlert Maureen O. Wilson, Ph.D. For extraordinary dedication and competence in ensuring that all NCI employees personally received training the area of financial conflicts of interest Jill I. Johnson, B.S. Cherie M. Nichols, M.B.A. Lisa M. Stevens, Ph.D. For outstanding leadership in exploring and implementing a novel partnership framework to accomplish NCI's mission Marianne P. Kost, B.A. Kathryn B. McNeill, M.A. Kathie Reed, M.S. Kathy Sorrow This group provided exemplary leadership and analytical support for refocusing NCI's Annual Plan and Budget Proposal around the strategic priority areas identified by Institute leadership Jeffrey S. Abrams, M.D. Christine D. Berg, M.D. Kenneth L. Bielat, Ph.D Peter L. Choyke, M.D. Travis M. Earles Melinda G. Hollingshead, D.V.M., Ph.D. Anna T. Levy, M.S Cherie M. Nichols, M.B.A. Marguerite Raaen, Ph.D. John A. Sogn, Ph.D. Lisa M. Stevens, Ph.D. Daniel C. Sullivan, M.D. Joseph E. Tomaszewski, Ph.D. Linda K. Weiss, Ph.D. For your central contribution as a member of NCI's first Integration/Implementation Team, and your scientific leadership developing a suite of enterprise-wide imaging initiatives that support the 2015 goal José L. Acosta, M.A. Robyn C. Bason, B.S. Bernice Evans Belt Nina Y. Bobbit Mary Anne Bright, R.N., M.N. Candace M. Deaton, M.P.A. Annette L. Galassi, R.N., M.A. Heather M. Hagood, M.P.P. Mary Beth Kelley, M.P.H. Madeline R. La Porta, M.S. MaryAnn C. Monroe, B.A. Catherine A. Muha, R.N., M.S.N. Judith Patt, M.S. Deborah C. Pearson, R.N., M.P.H Geriann Piazza, M.A. Sylvie Richards Diane C. Ruesch, B.A. Linda C. Slan, M.S. Linda B. Squiers, Ph.D. Debra A. Steverson, M.A. Allison Z. Turner Robert J. Zablocki For outstanding leadership in contract management, program planning, cost savings, and quality management of the NCI's Cancer Information Service.		Kathleen A. Foster, R.N., B.A. Margaret G. House, R.N., B.S.N., O.C.N. Erin J. Iturriaga, R.N., C.C.R.C. Beverly J. Meadows, M.S., R.N., O.C.N. Ellen S. Richmond, M.S., R.N. Anne M. Ryan, R.N. Judith J. Smith, M.S.N., R.N., A.O.C.N. For originating SCORE, developing early phase clinical trial infrastructure and disseminating bioinformatics applications supporting the DCP Phase I/II Cancer Prevention Consortia Cindy D. Davis, Ph.D. Young S. Kim, Ph. D. John A. Milner, Ph.D. Sharon A. Ross, Ph.D., M.P.H. Harold E. Seifried, Ph.D. Elaine B. Trujillo, M.S., R.D. Jacqueline B. Whitted, Ph.D. For leadership in advancing research to define the molecular mechanism(s) involved with bioactive food components and cancer prevention Peter D. Inskip, Sc.D. Cecile M. Ronckers, Ph.D. Alice J. Sigurdson, Ph.D. For notable discoveries in quantifying and characterizing dose-response patterns in radiation related second malignancies among long-term survivors of childhood cancer Mary Brough Emond, B.S. Jennifer E. Ojeda Faith M. Prigal Gwendolyn M. Proctor Bridgette A. Tobiassen Outstanding service in support of the peer review and advisory council activities of the Division of Extramural Activities Sally Z. Hausman, M.A. Carolyn M. Laurencot, Ph.D. In recognition of their efforts to expedite the timely transfer of novel anticancer agents developed by the extramural investigators to the clinic Thomas A. Davis, M.D. John J. Wright, M.D., Ph.D. For successful efforts to promote the clinical development farnesyltransferase inhibitors for the treatment of adult patients with acute myelogenous leukemia Andrea M. Denicoff, R.N., M.S., C.A.N.P. Molla S. Donaldson, Dr.P.H., M.S. Ann M. O'Mara, Ph.D, M.P.H., R.N. Julia H. Rowland, Ph.D. Edward L.Trimble, M.D., M.P.H. For leadership in guiding the NCI's efforts to reduce the suffering due to cancer by promoting palliative care research and the delivery of effective symptom management Lynn M. Amende, Ph.D. Robert E. Bird, Ph. D. Ilda M. McKenna, Ph.D. Virginia Pollan Wray, Ph.D. Outstanding efforts in the development of a new review guide for peer reviewers serving on NCI DEA committees Margaret Bell Adamo, R.H.I.T., C.T.R. April G. Fritz, B.A, R.H.I.T., C.T.R. Carol H. Johnson, B.S., C.T.R. Steven K. Peace, B.S., C.T.R. For the development and implementation of quality improvement methods and procedures for the SEER program, resulting in significant improvement in data quality Demetrius Albanes, M.D. Margaret V. Ames, Ph.D. Audie A. Atienza, Ph.D. Noreen M. Aziz, M.D., Ph.D., M.P.H. Rachel M. Ballard- Barbash, M.D., M.P.H. L. Michelle Bennett, Ph.D. David A. Berrigan, Ph.D., M.P.H. Aaron E. Blair, Ph.D., M.P.H. Sarah J. Dash, M.P.H. Michele R. Forman, Ph.D., M.S. Virginia W. Hartmuller, Ph.D., R.D. Stephen D. Hursting, Ph.D., M.P.H. John A. Milner, Ph.D. Susan M. Krebs-Smith, M.P.H., Ph.D. Michael F. Leitzmann, M.D., Dr.P.H. Louise C. Mâsse, Ph.D. Susan A. McCarthy, Ph.D. Linda Nebeling, Ph.D. M.P.H., R.D., F.A.D.A Nancy A. Potischman, Ph.D. Julia H. Rowland, Ph.D. Arthur Schatzkin, M.D., M.P.H., Dr.P.H. Amy F. Subar, Ph.D., M.P.H. Richard P. Troiano, Ph.D. Stacey Vandor, M.P.A. Amy L. Yaroch, Ph.D. For exemplary leadership in advancing NCI's commitment to understanding the science of energy balance and cancer and applying that understanding to reduce the cancer burden Bradford W. Hesse, Ph.D. Kelly D. Blake, M.S., C.H.E.S. Richard P. Moser, Ph.D. Amy L. Yaroch, Ph.D. Helen I. Meissner, Sc.M., Ph.D. Gordon B. Willis, Ph.D. Neeraj K. Arora, Ph.D. For Innovation and dedication resulting in NCI's first ever Health Information National Trends Survey (HINTS) and accompanying Web site Michele H. Bloch, M.D., Ph.D. Anna T. Levy, M.S. For Outstanding leadership in developing and leading a public/private partnership to develop a report with action plan for improving woman's health by reducing tobacco-related cancers

Individual Awards

H. Richard Alexander, Jr., M.D.
For significant innovation in the development of novel and effective regional therapy techniques for patients with advanced solid organ cancers

Sheue-yann Cheng, Ph.D.
For exceptional accomplishment and outstanding leadership in creating mouse models to understand the molecular genetics of thyroid cancer and to develop prevention and treatment strategies

Phillip A. Dennis, M.D., Ph.D.
For identifying the P13K/Akt/mTOR pathway as a target for the prevention and treatment of lung cancer, and for the development of novel Akt inhibitors

Lothar Esser
For outstanding contributions to protein crystallography

Shiv I. S. Grewal, Ph.D.
For the discovery of the role of RNA interference in heterochromatin assembly, and the involvement of heterochromatin in genome organization.
Kristopher Krausz
For extraordinary service, technical skills, creativity and productivity that has markedly advanced the mission of the NIH intramural program
James B. McMahon, Ph.D.
Establishment of the CCR Molecular Targets Development Program and playing the primary leadership role in developing this into a successful program to fulfill the NCI mission
Tom Misteli, Ph.D.
Using novel in vivo imaging techniques to study the function of proteins in living cells, Dr. Misteli has let a reevaluation of the dynamic behavior of the nuclear transcriptional apparatus
Jeffrey S. Rubin, M.D., Ph.D.
For purifying keratinocyte growth factor and playing a major role in its development as an FDA-approved therapy for oral muscositis in patients receiving intensive chemoradiotherapy
David S. Salomon, Ph.D.
For Outstanding contributions to understanding the molecular mechanisms of Cripto-1 action in mammary gland development and tumorigenesis
Maria L.Turner, M.D.
Presented in recognition of sustaining outstanding performance as Director of the Dermatology Branch Consultation Service, valued Senior Clinician and mentor to Dermatology Branch Clinical Associates
Sue H. Wickner, Ph.D.
The award is for the discovery that Clp proteins are a new class of molecular chaperones and that chaperones act directly in ATP-dependent proteolysis

Gilbert Howlett Smith , Ph.D.
For outstanding research into understanding the role of the mammary stem cell niche in development and tumorigenesis
Grace Chao Yeh, Ph.D.
For outstanding contributions to the NCI in furthering cancer prevention research, service to the NCI, and for mentoring women scientists

Elizabeth C. Lovoy, J.D., M.P.H.
For outstanding dedication and achievement in support of the translation of new discoveries to the treatment of patients with cancer through CRADA partnerships
Valerie M. Secker, M.P.A.
For outstanding contributions toward a more efficient organization
James V. Lacey, Jr., M.P.H., Ph.D.
For his scientific contributions which have clarified the role of a variety of hormonal factors in the etiology of ovarian and endometrial cancers
Jacquelyn M. Havens, B.A.
For outstanding service in managing two large administrative resource centers during the implementation of the MEO for Extramural Support Services
Carla D. Floyd, M.S.
For providing an effective administrative infrastructure that expedites decision making and responds rapidly in a rapidly changing environment
S. Percy Ivy, M.D.
For her leadership in coordinating the development of standardized protocol templates of phase 1 studies in patients with renal and hepatic dysfunction
Barry D. Anderson, M.D., Ph.D.
For leadership in developing practical guidance and procedures that facilitate the joint conduct of clinical trials between NCI-sponsored US Groups and international organizations
Helen B. Stone, Ph.D.
For conceptualizing, organizing and reinvigorating radiobiology research of normal tissues and the development of countermeasures of radiation injury from cancer therapy and radiological/nuclear terrorism
Gary L. Smith, M.G.A.
Worked closely with the CIP to transfer images from sites to a PACS. This allowed review and confirmation of responding patients to promising new cancer treatment
Wendy R. Fredericks
For her outstanding support during the transition to DEAS, including training several DEAS staff to ensure that program staff, applicants and grantees were properly serviced
Mary Jane Slesinski, Ph.D.
For distinguished services as the "champion" for the peer review of the small grant programs in cancer epidemiology, prevention, and behavior
Gordon B. Willis, Ph.D.
For outstanding work in the areas of Human Subjects Protection and guidance to staff in OMB clearance procedures
Bryce B. Reeve, Ph.D.
For advancing the science and effectively representing the National Cancer Institutes on the NIH/s Roadmap initiative to build the Patient-Reported Outcomes Measurement Information System

Merit Awards Commissioned Corps

The PHS Citation
Judith L. Bader, M.D.

Leading Diversity Award

Viola Black
Paul A. Randazzo, M.D.

Length of Service Certificates

50-Year
Frank S. Harrington
40-Year
Ettore Appella
Linda M. Brown
Larry L. Claggett
John P. Hartinger
Turid A. Knutsen
James M. Phang
Gilbert H. Smith
Beverly L. Wyatt

Outstanding Mentor Award

Patricia S. Steeg, Ph.D.
Stephen I. Katz, M.D., Ph.D.
Graça M. Dores, M.D., M.P.H.
To acknowledge exemplary mentoring and guidance of trainees in cancer research

Mentors of Merit

R. Mark Simpson, D.V.M., Ph.D.
Susan M. Krebs-Smith, Ph.D., M.P.H., R.D.
Maryalice Stetler-Stevenson, M.D., Ph.D.
Scott K. Durum, Ph.D.
Sheue-yann Cheng, Ph.D.
Sandra M. Swain, M.D.
Mark Simpson, D.V.M., Ph.D.
For excellence in mentoring and guiding the careers of trainees in cancer research.